These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17404871)
1. Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation. Kita Y; Klintmalm G; Kobayashi S; Yanaga K Dig Dis Sci; 2007 Dec; 52(12):3392-3. PubMed ID: 17404871 [No Abstract] [Full Text] [Related]
2. Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation? Ringe B; Böker K; Schlitt HJ; Sproviero J; Hundrieser J; Tillmann HL; Chavan A; Flemming P; Galanski M; Pichlmayr R Clin Transplant; 1995 Jun; 9(3 Pt 1):190-6. PubMed ID: 7549059 [TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular cancer with a background of liver cirrhosis]. Zhuravlev VA; Agalakov VI Klin Med (Mosk); 1996; 74(2):2-5. PubMed ID: 8772088 [No Abstract] [Full Text] [Related]
4. Management of hepatocellular carcinoma: treatment options and indications for orthotopic liver transplantation. Khalid O; Bouneva I Mo Med; 2011; 108(4):264-8. PubMed ID: 21905443 [TBL] [Abstract][Full Text] [Related]
5. Living-donor liver transplant with an interposition graft of the inferior vena cava for hepatocellular carcinoma: beyond the Milan criteria and within the UCSF criteria. Ahn KS; Kang KJ; Kim HT; Kim YH; Park UJ; Lim TJ; Park TJ; Cho WH Exp Clin Transplant; 2013 Jun; 11(3):283-6. PubMed ID: 23176663 [TBL] [Abstract][Full Text] [Related]
7. Recurrent hepatitis C virus infection after liver transplantation. Arnold JC; Kraus T; Otto G; Müller HM; Hofmann W; Gmelin K; Goeser T; Kommerell B; Theilmann L Transplant Proc; 1992 Dec; 24(6):2646-7. PubMed ID: 1334594 [No Abstract] [Full Text] [Related]
8. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years. Nafady-Hego H; Elgendy H; Nafady A; Uemoto S Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537 [TBL] [Abstract][Full Text] [Related]
9. Is tumor biopsy necessary? Müllhaupt B; Durand F; Roskams T; Dutkowski P; Heim M Liver Transpl; 2011 Oct; 17 Suppl 2():S14-25. PubMed ID: 21744470 [No Abstract] [Full Text] [Related]
10. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659 [TBL] [Abstract][Full Text] [Related]
11. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation. Ward SC; Chang CY; Peng L; Liu LU Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. Zhao XY; Rakhda MI; Wang TI; Jia JD Transplant Proc; 2013 Mar; 45(2):824-7. PubMed ID: 23498828 [TBL] [Abstract][Full Text] [Related]
13. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries? Audet M; Panaro F; Piardi T; Wolf P Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722 [No Abstract] [Full Text] [Related]
14. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B. Torbenson M; Grover D; Boitnott J; Klein A; Molmenti E Transplant Proc; 2005 Jun; 37(5):2205-6. PubMed ID: 15964379 [TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387 [TBL] [Abstract][Full Text] [Related]
16. An unusual case, in Italy, of hepatocarcinoma characterized by portal hypertension and absence of cirrhosis. Nocente R; Silveri NG; Vecchio FM; Gasbarrini G Hepatogastroenterology; 2001; 48(41):1343-5. PubMed ID: 11677960 [TBL] [Abstract][Full Text] [Related]
17. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833 [TBL] [Abstract][Full Text] [Related]
18. A case report of de novo hepatocellular carcinoma after living donor liver transplantation. Yu S; Guo H; Zhuang L; Yu J; Yan S; Zhang M; Wang W; Zheng S World J Surg Oncol; 2013 Aug; 11(1):176. PubMed ID: 23915066 [TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of hepatocellular carcinoma in cirrhosis]. Farges O; Belghiti J Ann Chir; 1998; 52(6):535-42. PubMed ID: 9752503 [TBL] [Abstract][Full Text] [Related]
20. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study. Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK; Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]